AstraZeneca's Purplepill.com Tops the List of Most Visited Pharmaceutical Brand Web Sites in Q2 2008
Marketwatch
Thu, 10/9/08 - 12:18 pm
New York Analyst: Eli Lilly’s ImClone Acquisition Carries ‘Promise, Risks’
Midwest Business
Thu, 10/9/08 - 12:17 pm
Invitrogen raises its 2009 profit outlook based on expected cost savings from buyout
Yahoo/AP
Thu, 10/9/08 - 12:09 pm
Kissei Pharma Rises After U.S. Approves Prostate Pill
Bloomberg
Thu, 10/9/08 - 12:08 pm
Crunch paves way for pharma deals
Fierce Pharma
Thu, 10/9/08 - 12:07 pm
Watson wins regulatory OK for Rapaflo
Fierce Biotech
Thu, 10/9/08 - 12:06 pm
J&J names surgical chief to lead pharmaceuticals
Reuters
Thu, 10/9/08 - 12:13 pm
Drug stocks advance; Mylan climbs on debt-rate swap
Marketwatch
Thu, 10/9/08 - 12:02 pm
Inspire Initiates Phase 1 Trial of INS117548 For Glaucoma
Yahoo
Thu, 10/9/08 - 12:01 pm
Boston Scientific revises estimates
Bizjournals.com
Thu, 10/9/08 - 12:00 pm
Tim Brown: Sanofi Has Potential
Yahoo/TheStreet.com
Thu, 10/9/08 - 11:59 am
Lilly Gets Off Easy
Motley Fool
Thu, 10/9/08 - 11:58 am
4-Star Stocks Poised to Pop: Bristol-Myers Squibb
Motley Fool
Thu, 10/9/08 - 11:58 am
AstraZeneca a Hold on Generics
Yahoo/Zacks.com
Thu, 10/9/08 - 11:57 am
Health Winners & Losers: Genentech
Yahoo/TheStreet.com
Thu, 10/9/08 - 07:35 am
Celgene Valued at a Premium
Yahoo/Zacks.com
Thu, 10/9/08 - 07:34 am
Pfizer `Spun' Neurontin Study Results, Experts Say
Bloomberg
Thu, 10/9/08 - 07:33 am
Overheard In The Field
Thu, 10/9/08 - 09:02 am
The Last Word--For Now--On Dendreon
CNBC
Wed, 10/8/08 - 12:26 pm
Genmab to cut 101 jobs and trim drug portfolio
Star Ledger, NJ
Wed, 10/8/08 - 12:23 pm

Pages